<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Burleigh Medical Centre</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
            in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
            mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
            population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
        </p>
        <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
            it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
        </p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=practice+C85017">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
            send short or detailed feedback.
        </p>
        <h2>Prescribing where Burleigh Medical Centre is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=1001010Q0&amp;denomIds=10.1.1&amp;selectedTab=summary">Phenylbutazone</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>2030</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>7.57</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=1001010Q0AAABAB&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Phenylbutazone 100mg tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=090401020&amp;denomIds=9.4.1&amp;selectedTab=summary">Low protein grains/flours</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Foods for special diets</td>
      <td>216</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.89</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=090401020BCAAAA&amp;denomIds=9.4.1&amp;selectedTab=summary" target="_blank">Loprofin low protein rice : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=090401020BDAAA0&amp;denomIds=9.4.1&amp;selectedTab=summary" target="_blank">Promin low protein all purpose baking mix : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0704020AC&amp;denomIds=7.4.2&amp;selectedTab=summary">Darifenacin hydrobromide</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>317</td>
      <td>Drugs for urinary frequency enuresis and incontinence</td>
      <td>1571</td>
      <td>0.20</td>
      <td>0.01</td>
      <td>0.04</td>
      <td>5.16</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0704020ACAAAAAA&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Darifenacin 7.5mg modified-release tablets : 151</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0704020ACAAABAB&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Darifenacin 15mg modified-release tablets : 166</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0304010K0&amp;denomIds=3.4.1&amp;selectedTab=summary">Cyproheptadine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>16</td>
      <td>Antihistamines</td>
      <td>3142</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>4.65</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0304010K0AAABAB&amp;denomIds=3.4.1&amp;selectedTab=summary" target="_blank">Cyproheptadine 4mg tablets : 16</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=1001010AA&amp;denomIds=10.1.1&amp;selectedTab=summary">Meloxicam</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>452</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>2030</td>
      <td>0.22</td>
      <td>0.03</td>
      <td>0.04</td>
      <td>4.25</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=1001010AAAAAAAA&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Meloxicam 7.5mg tablets : 68</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=1001010AAAAABAB&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Meloxicam 15mg tablets : 383</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=1001010AAAAAJAJ&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Meloxicam 15mg orodispersible tablets sugar free : 1</a></div></td></tr></tbody></table>

        <h2>Prescribing where Burleigh Medical Centre is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0309010C0&amp;denomIds=3.9.1&amp;selectedTab=summary">Codeine phosphate</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Cough suppressants</td>
      <td>10</td>
      <td>0.00</td>
      <td>0.76</td>
      <td>0.35</td>
      <td>-2.18</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0202010P0&amp;denomIds=2.2.1&amp;selectedTab=summary">Indapamide</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>163</td>
      <td>Thiazides and related diuretics</td>
      <td>1669</td>
      <td>0.10</td>
      <td>0.42</td>
      <td>0.16</td>
      <td>-2.04</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0202010P0AAAAAA&amp;denomIds=2.2.1&amp;selectedTab=summary" target="_blank">Indapamide 2.5mg tablets : 111</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0202010P0AAADAD&amp;denomIds=2.2.1&amp;selectedTab=summary" target="_blank">Indapamide 1.5mg modified-release tablets : 52</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=1106000AC&amp;denomIds=11.6&amp;selectedTab=summary">Brinzolamide</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>22</td>
      <td>Treatment of glaucoma</td>
      <td>1174</td>
      <td>0.02</td>
      <td>0.09</td>
      <td>0.04</td>
      <td>-1.91</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=1106000ACAAAAAA&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Brinzolamide 10mg/ml eye drops : 22</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=1105000B0&amp;denomIds=11.5&amp;selectedTab=summary">Atropine sulfate</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Mydriatics and cycloplegics</td>
      <td>5</td>
      <td>0.00</td>
      <td>0.72</td>
      <td>0.38</td>
      <td>-1.91</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0408020W0&amp;denomIds=4.8.2&amp;selectedTab=summary">Midazolam hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Drugs used in status epilepticus</td>
      <td>11</td>
      <td>0.27</td>
      <td>0.79</td>
      <td>0.30</td>
      <td>-1.72</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0408020W0BBADAD&amp;denomIds=4.8.2&amp;selectedTab=summary" target="_blank">Buccolam 10mg/2ml oromucosal soln pre-filled oral syringes : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C85017&amp;numIds=0408020W0BBABAB&amp;denomIds=4.8.2&amp;selectedTab=summary" target="_blank">Buccolam 5mg/1ml oromucosal soln pre-filled oral syringes : 1</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>